Chinese AI drug researcher XtalPi expects to turn first annual profit on 193% revenue jump

Chinese artificial intelligence-powered drug researcher XtalPi Holdings said it expects to turn its first annual profit on the back of strong revenue growth, according to a corporate filing. The Shenzhen-based company projected a swing to a net profit of at least 100 million yuan (US$14.5 million) in 2025 from a net loss of around 1.5 billion yuan in 2024, notching its first full-year profit, according to a filing with the Hong Kong stock exchange on Tuesday. XtalPi attributed the earnings boost...


8 d.
Economics
ID: -6530372775482159276


Similar News expand_more


Economics
Economics
Economics
Economics
Economics
Economics
Technology
Technology
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Technology
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Technology
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Technology
Science
Economics
Economics
Economics
Economics
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down